![]() |
|
|
Vol. 60, Issue 6, 1325-1331, December 2001
Graduate Programs in Molecular and Systems Pharmacology (S.C.M.)
and Biochemistry and Cell & Developmental Biology (H.Y.) and the
Department of Pharmacology (H.F.), Emory University School of Medicine,
Atlanta, Georgia; and the Department of Neurobiology,
Harvard Medical School, Boston, Massachusetts (S.R.D., M.E.G.)
14-3-3 proteins are a family of multifunctional phosphoserine binding
molecules that can serve as effectors of survival signaling. Understanding the molecular basis for the prosurvival effect of 14-3-3 may lead to the development of agents useful in the treatment of
disorders involving dysregulated apoptosis. One target of 14-3-3 is the
proapoptotic Bcl-2 family member Bad. Serine phosphorylation of Bad is
associated with 14-3-3 binding and inhibition of Bad-induced cell
death, but the relative contributions of the three known phosphorylation sites to 14-3-3 binding have not been established. Here
we demonstrate that S136 of Bad is vital for 14-3-3 interaction, but
S112 seems to be dispensable. 14-3-3/Bad interaction was strictly dependent on the presence of phosphorylated S136 in vitro, in yeast,
and in mammalian cells. However, mutation of S112 did not affect 14-3-3 binding. The death caused by wild-type and S112A Bad, but not that
caused by S136A Bad, could be almost completely abrogated by 14-3-3. These data support a critical role for 14-3-3 in regulating Bad
proapoptotic activity. The effect of 14-3-3 on Bad is controlled
largely by phosphorylation of S136, whereas S112 may represent a
14-3-3-independent pathway.
This article has been cited by other articles:
![]() |
A. Chahdi and A. Sorokin Protein Kinase A-Dependent Phosphorylation Modulates {beta}1Pix Guanine Nucleotide Exchange Factor Activity through 14-3-3{beta} Binding Mol. Cell. Biol., March 1, 2008; 28(5): 1679 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hekman, S. Albert, A. Galmiche, U. E. E. Rennefahrt, J. Fueller, A. Fischer, D. Puehringer, S. Wiese, and U. R. Rapp Reversible Membrane Interaction of BAD Requires two C-terminal Lipid Binding Domains in Conjunction with 14-3-3 Protein Binding J. Biol. Chem., June 23, 2006; 281(25): 17321 - 17336. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Qi, G. M. Wildey, and P. H. Howe Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function J. Biol. Chem., January 13, 2006; 281(2): 813 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cote, M. Chiasson, M. R Peralta III, K. Lafortune, L. Pellegrini, and K. Toth Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus J. Physiol., August 1, 2005; 566(3): 821 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hashimoto, K. Hirose, and M. Iino BAD Detects Coincidence of G2/M Phase and Growth Factor Deprivation to Regulate Apoptosis J. Biol. Chem., July 15, 2005; 280(28): 26225 - 26232. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jin, M. Xin, and X. Deng Survival Function of Protein Kinase C{iota} as a Novel Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated Bad Kinase J. Biol. Chem., April 22, 2005; 280(16): 16045 - 16052. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yin, L. Chao, and J. Chao Kallikrein/Kinin Protects against Myocardial Apoptosis after Ischemia/Reperfusion via Akt-Glycogen Synthase Kinase-3 and Akt-Bad{middle dot}14-3-3 Signaling Pathways J. Biol. Chem., March 4, 2005; 280(9): 8022 - 8030. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Tran, W. S. McDonough, B. A. Savitch, T. F. Sawyer, J. A. Winkles, and M. E. Berens The Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)-Fibroblast Growth Factor-inducible 14 (Fn14) Signaling System Regulates Glioma Cell Survival via NF{kappa}B Pathway Activation and BCL-XL/BCL-W Expression J. Biol. Chem., February 4, 2005; 280(5): 3483 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Murriel, E. Churchill, K. Inagaki, L. I. Szweda, and D. Mochly-Rosen Protein Kinase C{delta} Activation Induces Apoptosis in Response to Cardiac Ischemia and Reperfusion Damage: A MECHANISM INVOLVING BAD AND THE MITOCHONDRIA J. Biol. Chem., November 12, 2004; 279(46): 47985 - 47991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, M. Kobayashi, K. Isatsu, T. Nishihara, T. Aiuchi, K. Nakaya, and K. Hasegawa Mechanisms Involved in Apoptosis of Human Macrophages Induced by Lipopolysaccharide from Actinobacillus actinomycetemcomitans in the Presence of Cycloheximide Infect. Immun., April 1, 2004; 72(4): 1856 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Goldman, L. Chen, and H. Fu Activation of Apoptosis Signal-regulating Kinase 1 by Reactive Oxygen Species through Dephosphorylation at Serine 967 and 14-3-3 Dissociation J. Biol. Chem., March 12, 2004; 279(11): 10442 - 10449. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Eisenmann, M. W. VanBrocklin, N. A. Staffend, S. M. Kitchen, and H.-M. Koo Mitogen-Activated Protein Kinase Pathway-Dependent Tumor-Specific Survival Signaling in Melanoma Cells through Inactivation of the Proapoptotic Protein Bad Cancer Res., December 1, 2003; 63(23): 8330 - 8337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Chiang, C. Kanies, K. W. Kim, W. B. Fang, C. Parkhurst, M. Xie, T. Henry, and E. Yang Protein Phosphatase 2A Dephosphorylation of Phosphoserine 112 Plays the Gatekeeper Role for BAD-Mediated Apoptosis Mol. Cell. Biol., September 15, 2003; 23(18): 6350 - 6362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Misra, S. Ghatak, A. Zoltan-Jones, and B. P. Toole Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan J. Biol. Chem., July 3, 2003; 278(28): 25285 - 25288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Taghiyev, N. V. Guseva, H. Harada, C. M. Knudson, O. W. Rokhlin, and M. B. Cohen Overexpression of BAD Potentiates Sensitivity to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Treatment in the Prostatic Carcinoma Cell Line LNCaP Mol. Cancer Res., May 1, 2003; 1(7): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Henshall, T. Araki, C. K. Schindler, J.-Q. Lan, K. L. Tiekoter, W. Taki, and R. P. Simon Activation of Bcl-2-Associated Death Protein and Counter-Response of Akt within Cell Populations during Seizure-Induced Neuronal Death J. Neurosci., October 1, 2002; 22(19): 8458 - 8465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Kim, B. C. Kim, I. Y. Kim, M. Mamura, D. H. Seong, J.-J. Jang, and S.-J. Kim Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer Cells J. Biol. Chem., August 30, 2002; 277(36): 32510 - 32515. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Tran, D. G. Adams, R. R. Vaillancourt, and R. L. Heimark Signal Transduction from N-cadherin Increases Bcl-2. REGULATION OF THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt PATHWAY BY HOMOPHILIC ADHESION AND ACTIN CYTOSKELETAL ORGANIZATION J. Biol. Chem., August 30, 2002; 277(36): 32905 - 32914. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Powell, M. J. Rane, Q. Chen, S. Singh, and K. R. McLeish Identification of 14-3-3zeta as a Protein Kinase B/Akt Substrate J. Biol. Chem., June 7, 2002; 277(24): 21639 - 21642. [Abstract] [Full Text] [PDF] |
||||